{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:44:12Z","timestamp":1787237052822,"version":"build-2736575974"},"reference-count":45,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Objectives: An association between erythropoietin (Epo) administration and infantile hemangiomas (IH) in preterm infants was previously described; however, scarce data exists on a newer drug, darbepoetin (Darbe) and IH. We aimed to determine whether Darbe treatment was associated with IH in our preterm population. Methods: Retrospective observational cohort study including a consecutive sample of premature babies born &lt; 32 weeks at a single tertiary center between the years 2012\u20132023. We compared the rate of IH with Epo exposure, Darbe exposure and no exposure. Results: The cohort comprised 390 infants: 262 infants with no exposure, 36 infants with Epo exposure, and 92 infants with Darbe exposure. Exposed infants had significantly lower birth weight and gestational age compared to non-exposed infants. No differences were found in gestational age or birth weight between the two drug exposure groups. The rate of IH was 6.8%, 8.3% and 18.4% in the no exposure, Epo exposure and Darbe exposure groups, respectively. The rate of IH in the Darbe group was significantly higher compared to the non-exposed group (p = 0.003), and Darbe exposure was found to be significantly correlated with IH in a multiple logistic regression model (OR 3.07, 95% CI 1.5\u20136.2; p = 0.002). However, after adjusting for gestational age or birth weight, this correlation was no longer significant. Conclusions: Darbe exposure was associated with a higher rate of IH than no exposure in this cohort, but the association did not persist after adjustment for maturity, and the design does not allow us to distinguish the effect of Darbe from the effect of prematurity itself. Further prospective studies are needed to ascertain these findings.<\/jats:p>","DOI":"10.3390\/jcm15166445","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:48:31Z","timestamp":1787219311000},"page":"6445","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Darbepoetin and Infantile Hemangioma in Premature Infants"],"prefix":"10.3390","volume":"15","author":[{"given":"Irit","family":"Shoris","sequence":"first","affiliation":[{"name":"Neonatal Intensive Care Unit, Bnai Zion Medical Center, Haifa 31048, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5937-9620","authenticated-orcid":false,"given":"Arieh","family":"Riskin","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Bnai Zion Medical Center, Haifa 31048, Israel"},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa 32000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livnat","family":"Sharkansky","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Bnai Zion Medical Center, Haifa 31048, Israel"},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa 32000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Zoabi-Safadi","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Bnai Zion Medical Center, Haifa 31048, Israel"},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa 32000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adir","family":"Iofe","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Bnai Zion Medical Center, Haifa 31048, Israel"},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa 32000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arina","family":"Toropine","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Bnai Zion Medical Center, Haifa 31048, Israel"},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa 32000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bader","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Bnai Zion Medical Center, Haifa 31048, Israel"},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa 32000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1897-4754","authenticated-orcid":false,"given":"Ayala","family":"Gover","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Bnai Zion Medical Center, Haifa 31048, Israel"},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa 32000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e370","DOI":"10.1542\/neo.24-6-e370","article-title":"Red Blood Cell Transfusion Thresholds for Anemia of Prematurity","volume":"24","author":"Holzapfel","year":"2023","journal-title":"NeoReviews"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/vox.13622","article-title":"Characteristics of red blood cell transfusion among very preterm infants in China","volume":"119","author":"Zheng","year":"2024","journal-title":"Vox Sang."},{"key":"ref_3","first-page":"88","article-title":"Effects of Red Blood Cell Transfusions on the Risk of Developing Complications or Death: An Observational Study of a Cohort of Very Low Birth Weight Infants","volume":"34","author":"Ghirardello","year":"2017","journal-title":"Am. J. Perinatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.95.1.1","article-title":"Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants","volume":"95","author":"Shannon","year":"1995","journal-title":"Pediatrics"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-3476(05)80303-8","article-title":"Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity","volume":"119","author":"Ohls","year":"1991","journal-title":"J. Pediatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199404283301701","article-title":"The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group","volume":"330","author":"Maier","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0022-3476(97)70089-1","article-title":"The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: A randomized, double-blind, placebo-controlled study","volume":"131","author":"Ohls","year":"1997","journal-title":"J. Pediatr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0022-3476(05)82552-1","article-title":"Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants","volume":"121","author":"Carnielli","year":"1992","journal-title":"J. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.clp.2008.09.009","article-title":"Anemia in the preterm infant: Erythropoietin versus erythrocyte transfusion\u2014It\u2019s not that simple","volume":"36","author":"Ehrenkranz","year":"2009","journal-title":"Clin. Perinatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1542\/peds.2013-0143","article-title":"A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants","volume":"132","author":"Ohls","year":"2013","journal-title":"Pediatrics"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"F45","DOI":"10.1136\/adc.2010.187344","article-title":"An association between infantile haemangiomas and erythropoietin treatment in preterm infants","volume":"97","author":"Doege","year":"2012","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"ref_12","first-page":"e34","article-title":"Diffuse neonatal hemangiomatosis in a very low-birthweight infant treated with erythropoietin","volume":"57","author":"Okuno","year":"2015","journal-title":"Pediatr. Int.\u2014Off. J. Jpn. Pediatr. Soc."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Re\u0161i\u0107, A., Bar\u010dot, Z., Habek, D., Pogoreli\u0107, Z., and Ba\u0161kovi\u0107, M. (2025). The Evaluation, Diagnosis, and Management of Infantile Hemangiomas-A Comprehensive Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14020425"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Bellinato, F., Marocchi, M., Pecoraro, L., Zaffanello, M., Del Giglio, M., Girolomoni, G., Piacentini, G., and Rigotti, E. (2024). Diagnosis and Treatment of Infantile Hemangioma from the Primary Care Paediatricians to the Specialist: A Narrative Review. Children, 11.","DOI":"10.3390\/children11111397"},{"key":"ref_15","unstructured":"Cloherty, J.P., Eichenwald, E.C., and Stark, A.R. (2012). Manual of Neonatal Care, Lippincott Williams & Wilkins. [7th ed.]."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12519-019-00327-2","article-title":"Risk factors for infantile hemangioma: A meta-analysis","volume":"16","author":"Ding","year":"2020","journal-title":"World J. Pediatr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jaad.2021.08.019","article-title":"Infantile hemangioma. Part 1: Epidemiology, pathogenesis, clinical presentation and assessment","volume":"85","author":"Sebaratnam","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/ijd.17062","article-title":"The prevalence, complications, and risk factors for infantile hemangioma: A systematic review and meta-analysis","volume":"63","author":"Sun","year":"2024","journal-title":"Int. J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Sandru, F., Turenschi, A., Constantin, A.T., Dinulescu, A., Radu, A.M., and Rosca, I. (2023). Infantile Hemangioma: A Cross-Sectional Observational Study. Life, 13.","DOI":"10.3390\/life13091868"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jpeds.2008.05.043","article-title":"Infantile hemangiomas: An emerging health issue linked to an increased rate of low birth weight infants","volume":"153","author":"Drolet","year":"2008","journal-title":"J. Pediatr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/apa.13460","article-title":"Risk factors and morbidity of infantile haemangioma: Preterm birth promotes ulceration","volume":"105","author":"Salminen","year":"2016","journal-title":"Acta Paediatr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"117181","DOI":"10.1016\/j.biopha.2024.117181","article-title":"Insights into the mechanisms of angiogenesis in infantile hemangioma","volume":"178","author":"Xiang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood.V93.8.2627","article-title":"Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo","volume":"93","author":"Ribatti","year":"1999","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Zhu, Z., Jiang, X., Wang, F., Zhao, L., and Song, Q. (2025). Decoding infantile hemangioma: Cellular dynamics, molecular signals, and microenvironmental influences. Front Oncol., 15.","DOI":"10.3389\/fonc.2025.1675194"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"McVicar, C.M., Colhoun, L.M., Abrahams, J.L., Kitson, C.L., Hamilton, R., Medina, R.J., Durga, D., Gardiner, T.A., Rudd, P.M., and Stitt, A.W. (2010). Differential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathy. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011870"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1651-2227.2003.tb00511.x","article-title":"Recombinant human erythropoietin might induce strawberry haemangiomas in very-low-birthweight preterm infants","volume":"92","author":"Zaffanello","year":"2003","journal-title":"Acta Paediatr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1080\/080352500750043864","article-title":"Multiple strawberry haemangiomas-side effect of rHuEPO?","volume":"89","author":"Leung","year":"2000","journal-title":"Acta Paediatr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1907423","article-title":"A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants","volume":"382","author":"Juul","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jpeds.2015.02.052","article-title":"Safety of Early High-Dose Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants","volume":"167","author":"Koller","year":"2015","journal-title":"J. Pediatr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1542\/peds.2007-0803","article-title":"Infantile hemangiomas and retinopathy of prematurity: Possible association","volume":"123","author":"Praveen","year":"2009","journal-title":"Pediatrics"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000521413","article-title":"Association of Infantile Hemangiomas and Retinopathy of Prematurity: Analysis of the Multicenter KID","volume":"7","author":"Dankhara","year":"2022","journal-title":"Biomed. Hub."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1525-1470.1986.tb00535.x","article-title":"Strawberry hemangioma in preterm infants","volume":"3","author":"Amir","year":"1986","journal-title":"Pediatr. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"F85","DOI":"10.1136\/archdischild-2014-306197","article-title":"Incidence and treatment of infantile haemangioma in preterm infants","volume":"100","author":"Goelz","year":"2015","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1001\/archderm.138.12.1567","article-title":"Hemangiomas of infancy: Clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex","volume":"138","author":"Chiller","year":"2002","journal-title":"Arch. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/ppul.25837","article-title":"Erythropoietin for preventing bronchopulmonary dysplasia in preterm infants: A systematic review and meta-analysis","volume":"57","author":"Li","year":"2022","journal-title":"Pediatr. Pulmonol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jamapediatrics.2025.0807","article-title":"Darbepoetin, Red Cell Mass, and Neuroprotection in Preterm Infants: A Randomized Clinical Trial","volume":"179","author":"Ohls","year":"2025","journal-title":"JAMA Pediatr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1164\/rccm.201812-2348OC","article-title":"The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach","volume":"200","author":"Jensen","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_39","unstructured":"Jensen, E.A., Hibbs, A.M., Ohls, R.K., Colaizy, T., Tan, S., Patel, R.M., Das, A., and DeMauro, S. (2024, January 2\u20136). Effect of Darbepoetin on Respiratory Outcomes through 2 Years\u2019 Corrected Age in Preterm Infants: Secondary Results of the NICHD Neonatal Research Network (NRN) Darbe Trial. Presented at the Pediatric Academic Societies (PAS) Meeting, Toronto, ON, Canada. Abstract nr 2400.1."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","article-title":"Bronchopulmonary dysplasia","volume":"163","author":"Jobe","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00431-013-1966-y","article-title":"Infantile hemangiomas and retinopathy of prematurity: Clues to the regulation of vasculogenesis","volume":"172","author":"Hyland","year":"2013","journal-title":"Eur. J. Pediatr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.earlhumdev.2011.01.027","article-title":"Erythropoietin and retinopathy of prematurity","volume":"87","author":"Romagnoli","year":"2011","journal-title":"Early Hum. Dev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/s41372-024-01929-z","article-title":"Erythropoietin and retinopathy of prematurity: A retrospective cohort study in Japan, 2008\u20132018","volume":"44","author":"Fukui","year":"2024","journal-title":"J. Perinatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1542\/neo.20-11-e622","article-title":"Update on Erythropoiesis-Stimulating Agents Administered to Neonates for Neuroprotection","volume":"20","author":"Maxwell","year":"2019","journal-title":"NeoReviews"},{"key":"ref_45","first-page":"CD004863","article-title":"Early erythropoiesis-stimulating agents in preterm or low-birthweight infants","volume":"5","author":"Anarna","year":"2026","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6445\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:10:18Z","timestamp":1787220618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":45,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15166445"],"URL":"https:\/\/doi.org\/10.3390\/jcm15166445","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}